Biorestorative Therapies, Inc. (BRTX) vs Virax Biolabs Group Limited (VRAX)
- Biorestorative Therapies, Inc. BRTX 1.52 +4.11%
- Virax Biolabs Group Limited VRAX 1.45 −10.49%
Biorestorative Therapies, Inc. and Virax Biolabs Group Limited are both Biotechnology companies. Biorestorative Therapies, Inc. and Virax Biolabs Group Limited are of similar size ($2.2M and $2.0M). Virax Biolabs Group Limited has the higher net margin (0.00% vs −3,089.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Virax Biolabs Group Limited leads on 8 and Biorestorative Therapies, Inc. on 4.
Valuation
Profitability
| Metric | BRTX | VRAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 92.09% | — | 65.16% |
| Operating margin | (3,974.66%) | — | 0.00% |
| Net margin | (3,089.30%) | 0.00% | 0.00% |
| Free cash flow margin | (3,302.04%) | 0.00% | 0.00% |
| Return on equity | (241.50%) | 0.00% | (56.36%) |
| Return on assets | (147.75%) | 0.00% | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack